Olin (NYSE:OLN – Free Report) had its price target cut by Piper Sandler from $57.00 to $51.00 in a report released on Wednesday, Benzinga reports. They currently have an overweight rating on the specialty chemicals company’s stock.
OLN has been the topic of a number of other research reports. KeyCorp reduced their price objective on Olin from $57.00 to $56.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. The Goldman Sachs Group cut their price target on Olin from $55.00 to $49.00 and set a “neutral” rating on the stock in a research note on Monday, July 29th. Wells Fargo & Company cut their price target on Olin from $48.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Monday, October 28th. UBS Group cut their price target on Olin from $59.00 to $51.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 9th. Finally, Royal Bank of Canada cut their price target on Olin from $52.00 to $48.00 and set an “outperform” rating on the stock in a research note on Tuesday. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Olin currently has a consensus rating of “Hold” and a consensus price target of $51.86.
Check Out Our Latest Stock Report on OLN
Olin Trading Down 0.4 %
Olin Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Thursday, November 14th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Thursday, November 14th. Olin’s dividend payout ratio (DPR) is presently 64.52%.
Hedge Funds Weigh In On Olin
Institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC boosted its position in shares of Olin by 429.8% during the second quarter. AQR Capital Management LLC now owns 610,153 shares of the specialty chemicals company’s stock worth $28,769,000 after buying an additional 494,976 shares during the period. Boston Partners boosted its position in shares of Olin by 7.7% during the first quarter. Boston Partners now owns 5,414,265 shares of the specialty chemicals company’s stock worth $317,897,000 after buying an additional 384,888 shares during the period. Lodge Hill Capital LLC boosted its position in shares of Olin by 78.9% during the first quarter. Lodge Hill Capital LLC now owns 510,000 shares of the specialty chemicals company’s stock worth $29,988,000 after buying an additional 225,000 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Olin by 5.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,741,007 shares of the specialty chemicals company’s stock worth $176,396,000 after buying an additional 194,755 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its position in shares of Olin by 2,778.3% during the second quarter. Cubist Systematic Strategies LLC now owns 168,582 shares of the specialty chemicals company’s stock worth $7,949,000 after buying an additional 162,725 shares during the period. 88.67% of the stock is owned by institutional investors.
Olin Company Profile
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
See Also
- Five stocks we like better than Olin
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Battle of the Retailers: Who Comes Out on Top?
- What Makes a Stock a Good Dividend Stock?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.